- Home
- FENC vs KEQU Comparison
FENC vs KEQU Comparison
Compare FENC & KEQU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENC
- KEQU
- Stock Information
- Founded
- FENC 1996
- KEQU 1906
- Country
- FENC United States
- KEQU United States
- Employees
- FENC N/A
- KEQU N/A
- Industry
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- KEQU Medical Specialities
- Sector
- FENC Health Care
- KEQU Industrials
- Exchange
- FENC Nasdaq
- KEQU Nasdaq
- Market Cap
- FENC 156.9M
- KEQU 183.8M
- IPO Year
- FENC 2001
- KEQU N/A
- Fundamental
- Price
- FENC $5.08
- KEQU $33.44
- Analyst Decision
- FENC Strong Buy
- KEQU
- Analyst Count
- FENC 2
- KEQU 0
- Target Price
- FENC $14.00
- KEQU N/A
- AVG Volume (30 Days)
- FENC 87.7K
- KEQU 29.2K
- Earning Date
- FENC 05-13-2025
- KEQU 03-12-2025
- Dividend Yield
- FENC N/A
- KEQU N/A
- EPS Growth
- FENC N/A
- KEQU 102.06
- EPS
- FENC N/A
- KEQU 5.90
- Revenue
- FENC $47,538,000.00
- KEQU $220,026,000.00
- Revenue This Year
- FENC $2.68
- KEQU N/A
- Revenue Next Year
- FENC $71.63
- KEQU N/A
- P/E Ratio
- FENC N/A
- KEQU $5.67
- Revenue Growth
- FENC 123.69
- KEQU 9.44
- 52 Week Low
- FENC $3.96
- KEQU $30.82
- 52 Week High
- FENC $10.07
- KEQU $71.33
- Technical
- Relative Strength Index (RSI)
- FENC 34.36
- KEQU 33.43
- Support Level
- FENC $5.02
- KEQU $31.35
- Resistance Level
- FENC $5.50
- KEQU $34.66
- Average True Range (ATR)
- FENC 0.41
- KEQU 2.59
- MACD
- FENC -0.03
- KEQU 0.15
- Stochastic Oscillator
- FENC 22.22
- KEQU 23.15
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About KEQU Kewaunee Scientific Corporation
Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.